Home >> Industry News >> CellNetix selects Proscia for digital pathology

CellNetix selects Proscia for digital pathology

image_pdfCreate PDF

Dec. 6, 2023—CellNetix Pathology and Laboratories and Proscia announced today that CellNetix has selected Proscia to digitize a portion of its volume of 1 million glass slides scanned per year.

“At CellNetix, we are mission-driven and pride ourselves on quality and delivering more precise results. Adopting digital pathology is critical to furthering this aim,” Kathleen Fondren, CEO of CellNetix, said in a press release. “Proscia has established itself as a leading player in the space, and we are confident that working with the team will enable us to quickly realize the unprecedented potential of this innovation.”

CAP TODAY
X